Product information. Cipro (ciprofloxacin hydrochloride [tablets]). West Haven, CT: Miles Pharmaceuticals, March 1991.
2.
Product information. Cipro IV (ciprofloxacin hydrochloride [for intravenous infusion]). West Haven, CT: Miles Pharmaceuticals, March 1991.
3.
PetersonLRQuickJNJensenBHomannSJohnsonSTenquistJ, Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates: Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S. aureus colonization. Arch Intern Med1990; 150:2151–5.
4.
BlumbergHMRimlandDCarrollDJTerryPWachsmuthIK. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. J Infect Dis1991; 163:1279–85.
5.
TrucksisMHooperDCWolfsonJS. Emerging resistance to fluoroquinolones in staphylococci: An alert. Ann Intern Med1991; 114:424–6.
6.
ThysJPJacobsFMotteS. Quinolones in the treatment of lower respiratory tract infections. Rev Infect Dis1989; 1 (suppl 15):S1212–9.
7.
HaddowAGreeneSHeinzGWantuckD. Ciprofloxacin (intravenous/oral) versus ceftazidime in lower respiratory tract infections. Am J Med1989; 87(suppl 5A):113S–5S.
8.
BossoJA. Use of ciprofloxacin in cystic fibrosis patients. Am J Med1989; 87(suppl 5A):123S–7S.
9.
ScheedUB. Use of quinolones in pediatrics. Eur J Clin Microbiol Infect Dis1991; 10:355–60.
10.
WinterJHMcCartneyCBinghamJ. Ciprofloxacin in the treatment of severe Legionnaires' disease. Rev Infect Dis1988; 10(suppl 1):S218–9.
11.
BaystonKFWantSCohenJ. A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. Am J Med1989; 87(suppl 5A):269S–73S.
12.
BrownAESmithG. Treatment of sepsis in patients with neoplastic diseases with intravenous ciprofloxacin. Am J Med1989; 87(suppl 5A):266S–8S.
13.
MeunierFZinnerSHGayaHCalandraTViscoliCKlasterskyJ, A prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. Antimicrob Agents Chemother1991; 35:873–8.
14.
KelseySMWoodMEShawE. Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients. Am J Med1989; 87(suppl 5A):274S–7S.
15.
FlahertyJPWaitleyDEdlinBGeorgeDArnowPO'KeefeP, Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Ann J Med1989; 87(suppl 5A):278S–82S.
16.
Philpott-HowardJNBarkerKFWadeJJKaczmarskiRSSmedleyJCMuftiGJ. Randomized multicenter study of ciprofloxacin and azlocillin vs. gentamicin and azlocillin in the treatment of febrile neutropenic patients. J Antimicrob Chemother1990; 26(suppl F):89–99.
17.
SmithGMLeylandMJFarrellLDGeddesAM. A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients. J Antimicrob Chemother1988; 21:647–55.
18.
ChildsSJ. Intravenous and oral ciprofloxacin versus intravenous ceftazidime for the treatment of severe urinary tract infections. Diagn Microbiol Infect Dis1990; 13:161–3.
19.
CoxCE. Brief report: Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections. Am J Med1989; 87(suppl 5A):157S–9S.
20.
PalmerDLKosterFT. Parenteral ciprofloxacin compared with ceftazidime in the treatment of serious upper and lower urinary tract infection. Diagn Microbiol Infect Dis1990; 13:157–60.
21.
PetersHJ. Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection. Eur J Clin Microbiol Infect Dis1986; 5:253–5.
22.
GombertMEduBouchetLAulicinoTMBerkowitzLBMacchiaRJ. Intravenous ciprofloxacin versus cefotaxime prophylaxis during transurethral surgery. Am J Med1989; 87(suppl 5A):250S–1S.
23.
CoxCE. Comparison of intravenous ciprofloxacin and intravenous cefotaxime for antimicrobial prophylaxis in transurethral surgery. Am J Med1989; 87(suppl 5A):252S–4S.
24.
KujathP. Antibiotic prophylaxis in biliary surgery: Ciprofloxacin versus ceftriaxone. Am J Med1989; 87(suppl 5A):255S–7S.
25.
ChristensenMMNeilsenKTKnesJMadsenPO. Single-dose preoperative prophylaxis in transurethral surgery: Ciprofloxacin versus cefotaxime. Am J Med1989; 87(suppl 5A):258S–60S.
26.
OppenheimBAHartleyJWLeeWBurnieJP. Outbreak of coagulase-negative staphylococcus highly resistant to ciprofloxacin in a leukemia unit. Br Med J1989; 299:294–7.